Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4hki | FLN | Tankyrase-2 | 2.4.2.30 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4hki | FLN | Tankyrase-2 | 2.4.2.30 | 1.000 | |
| 4avw | G18 | Tankyrase-2 | 2.4.2.30 | 0.728 | |
| 4bui | W2E | Tankyrase-2 | 2.4.2.30 | 0.672 | |
| 4l33 | F70 | Tankyrase-2 | 2.4.2.30 | 0.669 | |
| 4buf | F36 | Tankyrase-2 | 2.4.2.30 | 0.668 | |
| 5aku | 29F | Tankyrase-2 | 2.4.2.30 | 0.665 | |
| 4buu | F38 | Tankyrase-2 | 2.4.2.30 | 0.664 | |
| 4buv | 16I | Tankyrase-2 | 2.4.2.30 | 0.650 | |
| 4but | 31F | Tankyrase-2 | 2.4.2.30 | 0.633 | |
| 4l0s | 1UZ | Tankyrase-2 | 2.4.2.30 | 0.628 | |
| 4l32 | 1VF | Tankyrase-2 | 2.4.2.30 | 0.628 | |
| 4l0i | 1UW | Tankyrase-2 | 2.4.2.30 | 0.620 | |
| 4kzl | 20D | Tankyrase-2 | 2.4.2.30 | 0.606 | |
| 4l2f | 1V3 | Tankyrase-2 | 2.4.2.30 | 0.601 | |
| 4bux | F35 | Tankyrase-2 | 2.4.2.30 | 0.600 | |
| 3p0p | NNF | Tankyrase-2 | 2.4.2.30 | 0.598 | |
| 4l2k | 1V8 | Tankyrase-2 | 2.4.2.30 | 0.597 | |
| 4hlf | 15Z | Tankyrase-2 | 2.4.2.30 | 0.594 | |
| 4hlm | 16S | Tankyrase-2 | 2.4.2.30 | 0.591 | |
| 4l31 | F08 | Tankyrase-2 | 2.4.2.30 | 0.590 | |
| 4hlh | 20D | Tankyrase-2 | 2.4.2.30 | 0.587 | |
| 4kzu | A73 | Tankyrase-2 | 2.4.2.30 | 0.586 | |
| 4hl5 | 15W | Tankyrase-2 | 2.4.2.30 | 0.577 | |
| 4j21 | AJ6 | Tankyrase-2 | 2.4.2.30 | 0.573 | |
| 4bus | 32F | Tankyrase-2 | 2.4.2.30 | 0.569 | |
| 4iue | AJ4 | Tankyrase-2 | 2.4.2.30 | 0.569 | |
| 4bue | JQF | Tankyrase-2 | 2.4.2.30 | 0.568 | |
| 4hkn | LU2 | Tankyrase-2 | 2.4.2.30 | 0.567 | |
| 4l0v | 1V1 | Tankyrase-2 | 2.4.2.30 | 0.566 | |
| 4l2g | 1V4 | Tankyrase-2 | 2.4.2.30 | 0.562 | |
| 4bud | 29F | Tankyrase-2 | 2.4.2.30 | 0.558 | |
| 4hmh | F94 | Tankyrase-2 | 2.4.2.30 | 0.551 | |
| 4hkk | AGI | Tankyrase-2 | 2.4.2.30 | 0.550 | |
| 4buw | F33 | Tankyrase-2 | 2.4.2.30 | 0.543 | |
| 4bs4 | A64 | Tankyrase-2 | 2.4.2.30 | 0.542 | |
| 4pnr | G18 | Tankyrase-2 | 2.4.2.30 | 0.542 | |
| 4j22 | AJ7 | Tankyrase-2 | 2.4.2.30 | 0.537 | |
| 4krs | 1SX | Tankyrase-1 | 2.4.2.30 | 0.529 | |
| 4bj9 | UHB | Tankyrase-2 | 2.4.2.30 | 0.523 | |
| 4tkg | 09L | Tankyrase-2 | 2.4.2.30 | 0.509 | |
| 4j3m | AJ8 | Tankyrase-2 | 2.4.2.30 | 0.505 | |
| 4j3l | AJ5 | Tankyrase-2 | 2.4.2.30 | 0.500 | |
| 4tjy | 3GN | Tankyrase-2 | 2.4.2.30 | 0.494 | |
| 4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.479 | |
| 4l09 | 1UR | Tankyrase-2 | 2.4.2.30 | 0.473 | |
| 4i9i | 1DY | Tankyrase-1 | 2.4.2.30 | 0.472 | |
| 2ejz | SAH | Diphthine synthase | / | 0.460 | |
| 1q0r | AKT | Aclacinomycin methylesterase RdmC | 3.1.1.95 | 0.459 | |
| 4avu | LDR | Tankyrase-2 | 2.4.2.30 | 0.459 | |
| 4k4e | K4E | Tankyrase-1 | 2.4.2.30 | 0.459 | |
| 3uzw | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.458 | |
| 2dw4 | FAD | Lysine-specific histone demethylase 1A | 1 | 0.453 | |
| 1q0z | AKA | Aclacinomycin methylesterase RdmC | 3.1.1.95 | 0.450 | |
| 4bjb | P34 | Tankyrase-2 | 2.4.2.30 | 0.450 | |
| 3ozd | 4CT | S-methyl-5'-thioadenosine phosphorylase | / | 0.449 | |
| 4g2y | NI5 | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.449 | |
| 4msk | 2C8 | Tankyrase-1 | 2.4.2.30 | 0.449 | |
| 4br0 | AU1 | Ectonucleoside triphosphate diphosphohydrolase 2 | / | 0.448 | |
| 1ps9 | MDE | 2,4-dienoyl-CoA reductase | 1.3.1.34 | 0.447 | |
| 4kp6 | 1S1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.446 | |
| 4o9c | COA | Acetyl-CoA acetyltransferase | 2.3.1.9 | 0.446 | |
| 2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.445 | |
| 1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 3mau | PLR | Putative sphingosine-1-phosphate lyase | / | 0.442 | |
| 4nbb | 9CA | Terminal oxygenase component of carbazole | / | 0.441 | |
| 2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 |